We’re excited to announce that Linda Kniebel has joined PursueCare as our new Head of Enterprise Partnerships.  Linda brings 20+ years of healthcare experience spanning specialty pharmaceuticals, medical devices, and digital SaaS solutions. She has led initiatives in complex medication management, pharmacogenomics, remote patient monitoring,...

Dr. Jason Kirby, DO, MBA, DFASAM is schedule to be a session presenter at OMED25. Be sure to register today to attend his session and explore many others. Dr. Kirby is looking forward to aligning leadership, education, and patient care while connecting with DOs, residents,...

And How PursueCare Can Help Recently, the FDA has pushed for 7-OH Mitragynine, a high-potency form of Kratom sold in head shops, to be classified as a Schedule I substance. If approved, possession of this substance will become illegal, and many individuals dependent on it...

Imagine a patient who has just conquered heroin dependence—only to succumb to a cigarette or vaping habit that shatters their lungs, steals decades from their life, and leaves them vulnerable to cancer and heart disease. This scenario is heartbreakingly common. If we ignore tobacco dependence...